RadNet, Inc. has grown revenue 14% a year over three years and 13% a year over five. Revenue growth, 3-year annual rate: +14% (Diagnostics & Research median +8.4%). Revenue growth, 5-year rate: +13%, growth has picked up over the last three years. Years of annual history on file: 17, FY2009 to FY2025, as filed.

RDNTRadNet, Inc.

Healthcare

$70.89-7.3% 1Y

$70.89

$51.8752 weeks$84.48

Is it growing?

Watch

Operating margin narrowing (−3.6 points). That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.

1 to watch, 2 without data

Margin direction−3.6 points operatingSEC EDGAR · Jun 30, 2026

Trailing-twelve-month operating margin, 3.1% now against 6.7% a year earlier.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 78% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is RDNT growing?

RadNet, Inc. has grown revenue 14% a year over three years and 13% a year over five.

+14%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.4% · steady growth, ahead of inflation · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +13%
Revenue growth, 5-year rate · +14% over three · growth has picked up over the last three years
Years of annual history on file: 17
Years of annual history on file · FY2009 to FY2025, as filed

Details›